Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer

Clinical trial NCT02592356 · COMPLETED

Trial details

NCT number: NCT02592356
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Differentiated Thyroid Gland Carcinoma Malignant Adrenal Gland Pheochromocytoma Malignant Paraganglioma Thyroid Gland Medullary Carcinoma

Start date: 2015-11-16
Primary completion: 2024-03-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.